Astellas Showcases Scientific Advancements Across its Oncology Portfolio at 2024 ASCO Annual Meeting [Yahoo! Finance]
Astellas Unveils New, State-of-the-Art, $90 Million West Coast Innovation Center in the South San Francisco Biotech Corridor [Yahoo! Finance]
Astellas Unveils New, State-of-the-Art, $90 Million West Coast Innovation Center in the South San Francisco Biotech Corridor
Announcing More Customer Expansions [Yahoo! Finance]
Astellas' XTANDI™ (Enzalutamide) Granted European Commission Approval for Use in Additional Recurrent Early Prostate Cancer Treatment Setting [Yahoo! Finance]